[Newsletter] Round-Up of COVID-19 Vaccine Updates: Week Commencing November 30, 2020

With the news on the novel coronavirus pandemic ever-changing, and the search for COVID-19 vaccines still continuing, it is difficult to stay on top of the goings-on of the vaccines in development. To help you stay on top of things, Nidhi Parekh of The Shared Microscope writes weekly updates on the vaccines alone.

Struggling to keep up with the goings-on of the COVID-19 vaccines?! We’ve got you covered! Check out our weekly COVID-19 Newsletter for the latest information on COVID-19 drugs and vaccines. #TSMUpdates #VaccineInfo #COVID19Updates

Tweet

---

For weekly updates on the COVID-19 vaccines, please do not forget to subscribe using the form below:

---

COVID-19 Top Vaccines

There are currently 14 COVID-19 vaccines in the final phase of clinical trials. The final phase results of all these vaccines are currently awaited. For more information on the regulatory process for vaccines (which is a labyrinth), check out this post here.

1. The Oxford/AstraZeneca Vaccine

What is The Oxford/AstraZeneca Vaccine And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Last week, the University of Oxford has announced that interim data show their COVID-19 vaccine candidate is 70.4% effective, and tests on using a two-dose regimen show that it could be 90% effective.

This week, the researchers have announced that as the vaccine starts to get approval, they will be “unblinding” their study i.e. letting the volunteers know whether they received the placebo or the COVID-19 vaccine. 

---

2. The Moderna Vaccine

What is The Moderna Vaccine And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Earlier this week, Moderna confirms they have requested Emergency Use Authorization from the U.S. FDA for their COVID-19 vaccine candidate, mRNA1273. The vaccine is said to be 94% effective, as per the final results.

---

3. Sinovac’s CoronaVac Vaccine

What is The CoronaVac Vaccine And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Turkey‘s health minister announces plans to start using Sinovac’s candidate, CoronaVac, later this year as the number of COVID-19 cases surge in the country. The Turkish labs have confirmed that the shots are safe for use. 

---

4. Cansino’s Ad5-nCoV

What is Cansino’s Ad5-nCoV Vaccine And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

There have been no new updates on this vaccine this week. For our most recent update, check out our post here.

---

5. Unnamed Inactive Vaccine – Wuhan

What is The Inactive Virus Vaccine From Wuhan And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

There have been no new updates on this vaccine this week. For our most recent update, check out our post here.

---

6. Sinopharm’s BBIBP-CorV

What is Sinopharm’s BBIBP-CorV And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

There have been no new updates on this vaccine this week. For our most recent update, check out our post here.

---

7. Pfizer and BioNTech’s BNT162b2

What is Pfizer and BioNTech’s BNT162 Vaccine And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Earlier this week, the UK was the first country in the world to approve a COVID-19 vaccine — Pfizer and BioNTech’s BNT162b2. Similarly, Pfizer has submitted its vaccine to the U.S. FDA for approval which is currently awaited.  

---

8. The Russian Gam-COVID-Vac

What is the Gam-COVID-Vac And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

There have been no new updates on this vaccine this week. For our most recent update, check out our post here.

---

9. Novavax’s NVX-CoV2373

What is Novavax’s NVX-CoV2373 And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

This week, Novavax announced that they completed enrollment for Phase 3 clinical trials in the UK and Phase 2b trials in South Africa. The trial in the UK has completed an enrollment of 15,000 participants. In South Africa, 4,422 volunteers have been enrolled, including 245 medically stable, HIV-positive participants.

---

10. Johnson & Johnson’s JNJ-78436735/Ad26.CoV2-S

What is Johnson & Johnson’s COVID-19 Vaccine And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

There have been no new updates on this vaccine this week. For our most recent update, check out our post here.

---

11. Murdoch Children’s Research Institute’s BCG Vaccine Trial

What is Murdoch Children’s Research Institute Doing?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Phase 3 clinical trial results for this vaccine are still to be declared. Since the trials started, we haven’t had any updates on the use of the BCG vaccine against COVID-19.

---

12. Bharat BioTech’s Covaxin

What is Bharat BioTech’s Covaxin And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

There have been no new updates on this vaccine this week. For our most recent update, check out our post here.

---

13. The Medicago-GSK Coronavirus-Like Particle (CoVLP)

What is Medicago’s Coronavirus-Like Particle (CoVLP)?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

There have been no new updates on this vaccine this week. For our most recent update, check out our post here.

---

14. Anhui Zhifei Longcom and Chinese Academy of Medical Sciences Vaccine Candidate

What is Anhui Zhifei Longform’s vaccine based on?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

There have been no new updates on this vaccine this week. For our most recent update, check out our post here.

---

For weekly updates on the COVID-19 vaccines delivered straight to your inbox, please do not forget to subscribe using the form below: